For instance, this study identified recurrent PLAG1 and LYN rearrangements in four of five DLBCL/HGBCL cases suggests their potential as novel biomarkers, warranting further investigation into their oncogenic roles and therapeutic implications. Here, LYN is linked to diffuse large B-cell lymphoma.